287 related articles for article (PubMed ID: 27307491)
1. SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.
Wagner SA; Satpathy S; Beli P; Choudhary C
EMBO J; 2016 Sep; 35(17):1868-84. PubMed ID: 27307491
[TBL] [Abstract][Full Text] [Related]
2. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
[TBL] [Abstract][Full Text] [Related]
3. SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.
Elliott PR; Leske D; Hrdinka M; Bagola K; Fiil BK; McLaughlin SH; Wagstaff J; Volkmar N; Christianson JC; Kessler BM; Freund SM; Komander D; Gyrd-Hansen M
Mol Cell; 2016 Sep; 63(6):990-1005. PubMed ID: 27591049
[TBL] [Abstract][Full Text] [Related]
4. SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.
Kupka S; De Miguel D; Draber P; Martino L; Surinova S; Rittinger K; Walczak H
Cell Rep; 2016 Aug; 16(9):2271-80. PubMed ID: 27545878
[TBL] [Abstract][Full Text] [Related]
5. SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD.
Griewahn L; Müller-Foxworth M; Peintner L; Wissler M; Weiss M; Brauns-Schubert P; Massoumi R; Borner C; Groß O; Yabal M; Charvet C; Maurer U
Cell Rep; 2023 Jan; 42(1):111961. PubMed ID: 36640323
[TBL] [Abstract][Full Text] [Related]
6. SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.
Wei R; Xu LW; Liu J; Li Y; Zhang P; Shan B; Lu X; Qian L; Wu Z; Dong K; Zhu H; Pan L; Yuan J; Pan H
Genes Dev; 2017 Jun; 31(11):1162-1176. PubMed ID: 28701375
[TBL] [Abstract][Full Text] [Related]
7. SPATA2: New insights into the assembly of the TNFR signaling complex.
Schlicher L; Maurer U
Cell Cycle; 2017 Jan; 16(1):11-12. PubMed ID: 27635695
[No Abstract] [Full Text] [Related]
8. SPATA2: more than a missing link.
Schlicher L; Brauns-Schubert P; Schubert F; Maurer U
Cell Death Differ; 2017 Jul; 24(7):1142-1147. PubMed ID: 28282038
[TBL] [Abstract][Full Text] [Related]
9. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains.
Elliott PR; Leske D; Wagstaff J; Schlicher L; Berridge G; Maslen S; Timmermann F; Ma B; Fischer R; Freund SMV; Komander D; Gyrd-Hansen M
Cell Rep; 2021 Oct; 37(1):109777. PubMed ID: 34610306
[TBL] [Abstract][Full Text] [Related]
11. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
13. MST1 Negatively Regulates TNFα-Induced NF-κB Signaling through Modulating LUBAC Activity.
Lee IY; Lim JM; Cho H; Kim E; Kim Y; Oh HK; Yang WS; Roh KH; Park HW; Mo JS; Yoon JH; Song HK; Choi EJ
Mol Cell; 2019 Mar; 73(6):1138-1149.e6. PubMed ID: 30901564
[TBL] [Abstract][Full Text] [Related]
14. The role of SPATA2 in TNF signaling, cancer, and spermatogenesis.
Masola V; Greco N; Tozzo P; Caenazzo L; Onisto M
Cell Death Dis; 2022 Nov; 13(11):977. PubMed ID: 36402749
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.
Wieser V; Tsibulak I; Degasper C; Welponer H; Leitner K; Parson W; Zeimet AG; Marth C; Fiegl H
Cancer Sci; 2019 Mar; 110(3):1117-1126. PubMed ID: 30697874
[TBL] [Abstract][Full Text] [Related]
16. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
[TBL] [Abstract][Full Text] [Related]
17. Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death.
Kupka S; Reichert M; Draber P; Walczak H
FEBS J; 2016 Jul; 283(14):2626-39. PubMed ID: 26749412
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.
Erol A
Cancer Manag Res; 2022; 14():2339-2356. PubMed ID: 35958947
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.
Reiley W; Zhang M; Wu X; Granger E; Sun SC
Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263
[TBL] [Abstract][Full Text] [Related]
20. Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP.
Goto E; Tokunaga F
Biochem Biophys Res Commun; 2017 Mar; 485(1):152-159. PubMed ID: 28189684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
